Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Melastatin Expression in Predicting the Risk for Developing Local Regional Metastases of Primary Melanoma

NCT00049010 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT00049010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00049010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Melastatin Expression in Predicting the Risk for Developing Local Regional Metastases of Primary Melanoma
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2002
Completion date
October 31, 2009
Enrollment
314 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)